Miguel E. Mateu-Quinones
Dunedin, OTA 9016, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Engineering antigenic breadth against SARS-CoV-2 by pairing divergent RBDs within a single mRNA immunogen.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 26, 2026
Synthetic host defense peptide inhibits SARS-CoV-2 replication in vitro.
Journal: Antimicrobial agents and chemotherapy
Published: June 23, 2025
Inhalable spray-dried dry powders combining ivermectin and niclosamide to inhibit SARS-CoV-2 infection in vitro.
Journal: International journal of pharmaceutics
Published: November 08, 2024
Neuroproteomic Analysis after SARS-CoV-2 Infection Reveals Overrepresented Neurodegeneration Pathways and Disrupted Metabolic Pathways.
Journal: Biomolecules
Published: September 20, 2023
Repurposing ebselen as an inhalable dry powder to treat respiratory tract infections.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: September 08, 2023
Spray-Dried Inhalable Microparticles Combining Remdesivir and Ebselen against SARS-CoV-2 Infection.
Journal: Pharmaceutics
Published: August 03, 2023
Inhalable dry powder containing remdesivir and disulfiram: Preparation and in vitro characterization.
Journal: International journal of pharmaceutics
Published: August 02, 2023
Health nationalism in Aotearoa New Zealand during COVID-19: problems for global health equity.
Journal: Nature medicine
Published: July 18, 2023
Alternative options for treatment-experienced people with HIV.
Journal: AIDS (London, England)
Published: May 04, 2023
Virology under the Microscope-a Call for Rational Discourse.
Journal: mBio
Published: January 26, 2023
Virology under the Microscope-a Call for Rational Discourse.
Journal: mSphere
Published: January 26, 2023
Last Updated: 09/26/2026